Brooklyn ImmunoTherapeutics Total Assets 2006-2021 | BTX

Brooklyn ImmunoTherapeutics total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Brooklyn ImmunoTherapeutics Annual Total Assets
(Millions of US $)
2020 $4
2019 $14
2018 $15
2017 $17
2016 $17
2015 $16
2014 $22
2013 $15
2012 $13
2011 $12
2010 $13
2009 $14
2008 $12
2007 $21
2006 $27
2005 $30
Brooklyn ImmunoTherapeutics Quarterly Total Assets
(Millions of US $)
2021-09-30 $39
2021-06-30 $65
2021-03-31 $21
2020-12-31 $14
2020-09-30 $5
2020-06-30 $7
2020-03-31 $11
2019-12-31 $14
2019-09-30 $15
2019-06-30 $16
2019-03-31 $16
2018-12-31 $15
2018-09-30 $16
2018-06-30 $16
2018-03-31 $16
2017-12-31 $17
2017-09-30 $18
2017-06-30 $19
2017-03-31 $18
2016-12-31 $17
2016-09-30 $14
2016-06-30 $15
2016-03-31 $16
2015-12-31 $16
2015-09-30 $17
2015-06-30 $17
2015-03-31 $20
2014-12-31 $22
2014-09-30 $23
2014-06-30 $23
2014-03-31 $16
2013-12-31 $15
2013-09-30 $12
2013-06-30 $11
2013-03-31 $12
2012-12-31 $13
2012-09-30 $13
2012-06-30 $12
2012-03-31 $13
2011-12-31 $12
2011-09-30 $12
2011-06-30 $13
2011-03-31 $14
2010-12-31 $13
2010-09-30 $14
2010-06-30 $13
2010-03-31 $14
2009-12-31 $14
2009-09-30 $14
2009-06-30 $15
2009-03-31 $12
2008-12-31 $12
2008-09-30 $14
2008-06-30 $16
2008-03-31 $18
2007-12-31 $21
2007-09-30 $23
2007-06-30 $24
2007-03-31 $26
2006-12-31 $27
2006-09-30 $29
2006-06-30 $29
2006-03-31 $30
2005-12-31 $30
2005-09-30 $29
2005-06-30 $29
2005-03-31 $29
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.160B $0.006B
Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.033B 9.10
Bio-Rad Laboratories (BIO.B) United States $17.971B 36.47
QIAGEN (QGEN) Netherlands $11.044B 18.70
Biohaven Pharmaceutical Holding (BHVN) United States $7.729B 0.00
Emergent Biosolutions (EBS) United States $2.541B 9.14
Arcus Biosciences (RCUS) United States $2.414B 0.00
Myovant Sciences (MYOV) United Kingdom $1.374B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.167B 0.00
Zymeworks (ZYME) Canada $0.623B 0.00
Ambrx Biopharma (AMAM) United States $0.231B 0.00
SQZ Biotechnologies (SQZ) United States $0.214B 0.00
Enzo Biochem (ENZ) United States $0.161B 20.75